IO Biotech Net Income Over Time
| IOBT Stock | USD 0.28 0.01 3.45% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out IO Biotech Performance and IO Biotech Correlation. Is there potential for Biotechnology market expansion? Will IOBT introduce new products? Factors like these will boost the valuation of IO Biotech. Market participants price IOBT higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about IO Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
IO Biotech's market price often diverges from its book value, the accounting figure shown on IOBT's balance sheet. Smart investors calculate IO Biotech's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since IO Biotech's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between IO Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if IO Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IO Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Net Income Analysis
Compare IO Biotech and related stocks such as Werewolf Therapeutics, Spruce Biosciences Common, and Adicet Bio Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HOWL | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (11 M) | (14.9 M) | (49.8 M) | (51.6 M) | (37.4 M) | (70.5 M) | (63.5 M) | (60.3 M) |
| SPRB | (9.9 M) | (9.9 M) | (9.9 M) | (9.9 M) | (9.9 M) | (9.9 M) | (9.9 M) | (9.9 M) | (9.9 M) | (13.2 M) | (29.5 M) | (42.3 M) | (46.2 M) | (47.9 M) | (53 M) | (47.7 M) | (50.1 M) |
| ACET | 13.5 M | 9 M | 17 M | 22.3 M | 22.3 M | 29 M | (1000) | (33.8 M) | (9.3 M) | (28.1 M) | (36.7 M) | (62 M) | (69.8 M) | (142.7 M) | (117.1 M) | (105.4 M) | (100.1 M) |
| OTLK | (13.7 M) | (13.7 M) | (13.7 M) | (13.7 M) | (47.4 M) | (53.3 M) | (38.8 M) | (30.1 M) | (34.5 M) | (35.2 M) | (53.2 M) | (66.1 M) | (59 M) | (75.4 M) | (62.4 T) | (56.2 T) | (53.4 T) |
| CUE | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (1.9 M) | (7.7 M) | (23.2 M) | (39 M) | (36.7 M) | (44.8 M) | (44.2 M) | (53 M) | (50.7 M) | (40.7 M) | (36.6 M) | (38.4 M) |
| KPTI | (10.3 M) | (10.3 M) | (15.9 M) | (33.9 M) | (75.8 M) | (118.2 M) | (109.6 M) | (129 M) | (178.4 M) | (199.6 M) | (196.3 M) | (124.1 M) | (165.3 M) | (143.1 M) | (76.4 M) | (68.8 M) | (72.2 M) |
| NRXP | (105 K) | (105 K) | (105 K) | (105 K) | (105 K) | (105 K) | (105 K) | (105 K) | 66.1 K | 408.4 K | (51.8 M) | (93.1 M) | (39.8 M) | (30.1 M) | (25.1 M) | (22.6 M) | (23.7 M) |
| OSTX | (6 K) | (6 K) | (6 K) | (6 K) | (6 K) | (6 K) | (6 K) | (6 K) | (6 K) | (6 K) | (6 K) | (7.4 M) | (6.3 M) | (7.8 M) | (8.9 M) | (8 M) | (8.4 M) |
IO Biotech and related stocks such as Werewolf Therapeutics, Spruce Biosciences Common, and Adicet Bio Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in IO Biotech financial statement analysis. It represents the amount of money remaining after all of IO Biotech operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| IO Biotech | IOBT |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | Ole MaalOees Vej |
| Exchange | NASDAQ Exchange |
USD 0.28
Additional Tools for IOBT Stock Analysis
When running IO Biotech's price analysis, check to measure IO Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy IO Biotech is operating at the current time. Most of IO Biotech's value examination focuses on studying past and present price action to predict the probability of IO Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move IO Biotech's price. Additionally, you may evaluate how the addition of IO Biotech to your portfolios can decrease your overall portfolio volatility.